← All brands
Health & beauty
VectorY Therapeutics

VectorY Therapeutics

An Amsterdam biotech developing a gene therapy that lets nerve cells make their own antibody against ALS.

Amsterdam, Netherlands. Founded in August 2020 by Carlo Incerti, Pavlina Konstantinova, Anthony Newcombe and Barbara Sanders.

Raised 74.5 million euro for its ALS gene therapy VTx-002, reported by IO+ on 12 November 2026.

Written by our editors from public sources, linked in our story. Not a paid placement. Founders can request a correction.